BC
TMO icon

Bridgefront Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bridgefront Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,644
Closed -$1.79M – 751
2026
Q1 		$1.79M Buy
+3,644
New +$1.98M 0.45% 53
2025
Q3 		– Sell
-5,263
Closed -$2.13M – 835
2025
Q2 		$2.13M Buy
5,263
+3,197
+155% +$1.34M 0.57% 17
2025
Q1 		$1.03M Buy
2,066
+1,076
+109% +$583K 0.3% 79
2024
Q4 		$515K Sell
990
-5
-0.5% -$2.75K 0.17% 198
2024
Q3 		$615K Buy
995
+31
+3% +$18.4K 0.24% 136
2024
Q2 		$533K Buy
964
+142
+17% +$81.3K 0.22% 152
2024
Q1 		$478K Buy
822
+336
+69% +$189K 0.36% 76
2023
Q4 		$258K Sell
486
-18
-4% -$8.71K 0.19% 212
2023
Q3 		$255K Sell
504
-888
-64% -$473K 0.18% 254
2023
Q2 		$726K Buy
+1,392
New +$751K 0.39% 54
2021
Q2 		– Sell
-3,769
Closed -$1.72M – 904
2021
Q1 		$1.72M Buy
+3,769
New +$1.8M 0.54% 10

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bridgefront Capital's TMO Position: Q2 2026 in Review

Bridgefront Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,644 shares — an estimated $1.79M sold.

Bridgefront Capital first reported a position in TMO in Q1 2021 and held it in 11 quarters. The position peaked at $2.13M in Q2 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bridgefront Capital reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 3,644 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.79M.
  • Bridgefront Capital first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 11 quarters.
  • Bridgefront Capital's Thermo Fisher Scientific position peaked at $2.13M in Q2 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.